Line 1: |
Line 1: |
| [[FR: CIR nos activités]] | | [[FR: CIR nos activités]] |
− | <div style="background:#1F402B; | + | <div style="background:#6E8B7B; |
| color:white; | | color:white; |
| font-family:Arial; | | font-family:Arial; |
Line 10: |
Line 10: |
| </div> | | </div> |
| | | |
− | {| class="FCK__ShowTableBorders" style="border-right: 0px; border-top: 0px; border-left: 0px; border-bottom: 0px; background-color: #cfe2f3" width="100%" align="center" | + | {| class="FCK__ShowTableBorders" style="border-right: 0px; border-top: 0px; border-left: 0px; border-bottom: 0px; background-color: #C3D0C9" width="100%" align="center" |
| |- | | |- |
− | | style="border-right: white 1px solid; padding-right: 0px; padding-left: 0px; padding-bottom: 16px; padding-top: 10px; text-align: center; font-family: 'Helvetica Neue', Helvetica, Arial, sans-serif !important;font-size: 11pt;line-height:1.1;font-weight:bold;" width="11%" |[[Centre for Regulatory Innovation|<span style="color: #Black">Home</span>]] | + | | style="border-right: white 1px solid; padding-right: 0px; padding-left: 0px; padding-bottom: 16px; padding-top: 10px; text-align: center; font-family: 'Helvetica Neue', Helvetica, Arial, sans-serif !important;font-size: 11pt;line-height:1.1;font-weight:bold;" width="11%" |[[Centre for Regulatory Innovation|<span style="color: #252F38">Home</span>]] |
− | | style="border-right: white 1px solid; padding-right: 0px; padding-left: 0px; padding-bottom: 16px; padding-top: 16px; text-align: center; font-family: 'Helvetica Neue', Helvetica, Arial, sans-serif !important;font-size: 11pt;line-height:1.1;font-weight:bold;" width="11%" |<span style="color:#Black">[[CRI Events|Events]]</span> | + | | style="border-right: white 1px solid; padding-right: 0px; padding-left: 0px; padding-bottom: 16px; padding-top: 16px; text-align: center; font-family: 'Helvetica Neue', Helvetica, Arial, sans-serif !important;font-size: 11pt;line-height:1.1;font-weight:bold;" width="11%" |<span style="color:#252F38">[[CRI Events|Events]]</span> |
− | | style="border-right: white 1px solid; padding-right: 0px; padding-left: 0px; padding-bottom: 16px; padding-top: 16px; text-align: center; font-family: 'Helvetica Neue', Helvetica, Arial, sans-serif !important;font-size: 11pt;line-height:1.1;font-weight:bold;" width="11%" |<span style="color: #Black">[[What is Regulatory Experimentation?]]</span> | + | | style="border-right: white 1px solid; padding-right: 0px; padding-left: 0px; padding-bottom: 16px; padding-top: 16px; text-align: center; font-family: 'Helvetica Neue', Helvetica, Arial, sans-serif !important;font-size: 11pt;line-height:1.1;font-weight:bold;" width="11%" |<span style="color: #252F38">[[What is Regulatory Experimentation?]]</span> |
− | | style="border-right: white 1px solid; padding-right: 0px; padding-left: 0px; padding-bottom: 16px; padding-top: 16px; text-align: center; font-family: 'Helvetica Neue', Helvetica, Arial, sans-serif !important;font-size: 11pt;line-height:1.1;font-weight:bold;" width="11%" |<span style="color: #Black">[[Regulatory Experimentation Expense Fund]]</span> | + | | style="border-right: white 1px solid; padding-right: 0px; padding-left: 0px; padding-bottom: 16px; padding-top: 16px; text-align: center; font-family: 'Helvetica Neue', Helvetica, Arial, sans-serif !important;font-size: 11pt;line-height:1.1;font-weight:bold;" width="11%" |<span style="color: #252F38">[[Regulatory Experimentation Expense Fund]]</span> |
− | | style="border-right: white 1px solid; padding-right: 0px; padding-left: 0px; padding-bottom: 16px; padding-top: 16px; text-align: center; font-family: 'Helvetica Neue', Helvetica, Arial, sans-serif !important;font-size: 11pt;line-height:1.1;font-weight:bold;" width="11%" |<span style="color: #Black">[[Regulators' Capacity Fund]]</span> | + | | style="border-right: white 1px solid; padding-right: 0px; padding-left: 0px; padding-bottom: 16px; padding-top: 16px; text-align: center; font-family: 'Helvetica Neue', Helvetica, Arial, sans-serif !important;font-size: 11pt;line-height:1.1;font-weight:bold;" width="11%" |<span style="color: #252F38">[[Regulators' Capacity Fund]]</span> |
− | ! style="border-right: white 1px solid; padding-right: 0px; padding-left: 0px; padding-bottom: 16px; padding-top: 16px; text-align: center; font-family: 'Helvetica Neue', Helvetica, Arial, sans-serif !important;font-size: 11pt;line-height:1.1;font-weight:bold;" width="11%" |<span style="color: #Black">[[Regulators’ Capacity Fund Projects|Completed CRI Supported Projects]]</span> | + | ! style="border-right: white 1px solid; padding-right: 0px; padding-left: 0px; padding-bottom: 16px; padding-top: 16px; text-align: center; font-family: 'Helvetica Neue', Helvetica, Arial, sans-serif !important;font-size: 11pt;line-height:1.1;font-weight:bold;" width="11%" |<span style="color: #252F38">[[Regulators’ Capacity Fund Projects|Completed CRI Supported Projects]]</span> |
− | | style="padding-right: 0px; padding-left: 0px; padding-bottom: 16px; padding-top: 16px; text-align: center; font-family: 'Helvetica Neue', Helvetica, Arial, sans-serif !important;font-size: 11pt;line-height:1.1;font-weight:bold;" width="11%" |<span style="color: #Black">[[CRI Tools and Resources |Tools and Resources]]</span> | + | | style="padding-right: 0px; padding-left: 0px; padding-bottom: 16px; padding-top: 16px; text-align: center; font-family: 'Helvetica Neue', Helvetica, Arial, sans-serif !important;font-size: 11pt;line-height:1.1;font-weight:bold;" width="11%" |<span style="color: #252F38">[[CRI Tools and Resources |Tools and Resources]]</span> |
| |} | | |} |
| <div style="background: #ffae42; color:white; font-family:Arial;padding:10px">[[Image:Deadline.png |30px|left|Deadline]] <span style= "font-size: 10pt"> '''Expressions of Interest for the Regulatory Experimentation Expense Fund will be accepted until January 16, 2024.'''</span> | | <div style="background: #ffae42; color:white; font-family:Arial;padding:10px">[[Image:Deadline.png |30px|left|Deadline]] <span style= "font-size: 10pt"> '''Expressions of Interest for the Regulatory Experimentation Expense Fund will be accepted until January 16, 2024.'''</span> |